开设账户
模拟账户
关于我们
即时报价及新闻
市场分析
财经日历
每日市场分析
交易平台
下载及介绍
使用教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
繁
简
EN
客户登入
开设账户
模拟账户
繁
简
EN
客户登入
开设账户
模拟账户
关于我们
上志国际介绍
上志国际优势
即时报价及新闻
即时报价
即时新闻
市场分析
财经日历
市场分析
交易平台
平台特点
平台教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
关于我们
交易细则
贵金属市场
交易平台
市场分析
推广和资讯
常见问题
联络我们
繁
简
EN
沙特领导的联军:此次行动重点是切断胡塞武装在其控制区域之间的补给线。
2026-10-26
沙特领导的联军:此次行动重点是切断胡塞武装在其控制区域之间的补给线。
返回
其他消息
2026-10-25
Former Serbian president Vucic, after voting in parliamentary elections in Belgrade on the 25th, said he will accept the outcome responsibly and respect voters' will. He said preliminary results are expected between 22:00 and around midnight, which should give a rough indication of the winner.
Former Serbian president Vucic, after voting in parliamentary elections in Belgrade on the 25th, said he will accept the outcome responsibly and respect voters' will. He said preliminary results are expected between 22:00 and around midnight, which should give a rough indication of the winner.
2026-10-25
Pfizer said an experimental antibody‑drug conjugate, sigvotatug vedotin, failed to meet the primary endpoint in a trial of unresectable advanced lung cancer, showing no overall survival benefit versus chemotherapy. In a post‑hoc analysis presented at ESMO on Sunday, Pfizer reported that a subgroup of less‑heavily pretreated patients receiving the drug in combination showed survival more than two months longer than the chemotherapy control. Pfizer, which acquired the asset when it bought Seagen f
Pfizer said an experimental antibody‑drug conjugate, sigvotatug vedotin, failed to meet the primary endpoint in a trial of unresectable advanced lung cancer, showing no overall survival benefit versus chemotherapy. In a post‑hoc analysis presented at ESMO on Sunday, Pfizer reported that a subgroup of less‑heavily pretreated patients receiving the drug in combination showed survival more than two months longer than the chemotherapy control. Pfizer, which acquired the asset when it bought Seagen for $43 bln and had expected it to be a first‑in‑class product, said it will continue to pursue development and combination strategies.
Chat with us
, powered by
LiveChat